title: Emerging Genetic Counselor Roles within the Biotechnology and Pharmaceutical Industries: as Industry Interest Grows in Rare Genetic Disorders, How are Genetic Counselors Joining the Discussion?
abstract: Traditionally, the biotechnology and pharmaceutical industry (BPI) has focused drug development at the mass-market level targeting common medical issues. However, a recent trend is the development of therapies for orphan or rare disorders, including many genetic disorders. Developing treatments for genetic disorders requires an understanding of the needs of the community and translating genomic information to clinical and non-clinical audiences. The core skills of genetic counselors (GCs) include a deep knowledge of genetics and ability to communicate complex information to a broad audience, making GCs a choice fit for this shift in drug development. To date there is limited data defining the roles GCs hold within this industry. This exploratory study aimed to define the roles and motivation of GCs working in BPI, assess job satisfaction, and identify translatable skills and current gaps in GC training programs. The authors surveyed 26 GCs working in BPI in the United States; 79 % work for companies focused on rare disorders. GC positions in BPI are growing, with 57 % of respondents being the first GC in their role. GCs in BPI continue to utilize core genetic counseling competencies, though 72 % felt their training did not fully prepare them for BPI. These data suggest opportunities for exposure to BPI in GC training to better prepare future generations of GCs for these career opportunities. GC satisfaction was high in BPI, notably in areas traditionally reported as less satisfying on the National Society for Genetic Counselors Professional Status Survey: salary and advancement opportunities. BPI's growing interest in rare disorders represents a career opportunity for GCs, addressing both historic areas of dissatisfaction for GCs and BPI's genomic communication needs.
authors.affiliation: Boston University School of Medicine, Boston, MA, USA. tjlfield@bu.edu.
authors.forename: Tessa
authors.initials: T
authors.lastname: Field
authors.affiliation: Boston Children's Hospital, Boston, MA, USA.
authors.forename: Stephanie Jo
authors.initials: SJ
authors.lastname: Brewster
authors.affiliation: Boston Children's Hospital, Boston, MA, USA.
authors.forename: Meghan
authors.initials: M
authors.lastname: Towne
authors.affiliation: Boston University School of Medicine, Boston, MA, USA.
authors.forename: MaryAnn W
authors.initials: MW
authors.lastname: Campion
mesh_terms: D001709:Biotechnology; D000072117:Counselors / Q000193:education / Q000523:psychology*; D004345:Drug Industry; D004517:Education, Professional / Q000592:standards; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D007588:Job Satisfaction; D009042:Motivation; D035583:Rare Diseases / Q000235:genetics; D011795:Surveys and Questionnaires; D014481:United States
keywords: Biotechnology and pharmaceutical industry; Non-clinical genetic counseling roles; Professional issues; Training program development